Article Versions Notes

Damoiseaux D, Li W, Martínez-Chávez A, Beijnen JH, Schinkel AH, Huitema ADR, Dorlo TPC. Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs. Pharmaceuticals. 2022; 15(7):860. https://doi.org/10.3390/ph15070860

Damoiseaux, David, Wenlong Li, Alejandra Martínez-Chávez, Jos H. Beijnen, Alfred H. Schinkel, Alwin D. R. Huitema, and Thomas P. C. Dorlo. 2022. "Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs" Pharmaceuticals 15, no. 7: 860. https://doi.org/10.3390/ph15070860

Damoiseaux, D., Li, W., Martínez-Chávez, A., Beijnen, J. H., Schinkel, A. H., Huitema, A. D. R., & Dorlo, T. P. C. (2022). Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs. Pharmaceuticals, 15(7), 860. https://doi.org/10.3390/ph15070860